EGFR and neoplasm: While upregulation of the AR-target gene p21WAF1 promoted tumor cell proliferation through the MAPK pathway, hyperactivation of MAPK by concurrent AR and EGFR-signaling pathways caused tumor growth suppression [88, 89].